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Background: In the Indian ayurvedic system of medicine, Nymphaea nouchali is used for the treatment of diabetes,
cutaneous diseases, inflammation, liver disorders, urinary disorders, menorrhagia, blenorrhagia, menstruation
problem, as an aphrodisiac, and as a bitter tonic. However, despite its traditional usage as an antimicrobial agent,
there is no information regarding its effectiveness in infections caused by pathogenic microbes. Hence, we
evaluated 70% ethanol extract of the seeds of N. nouchali for its antimicrobial activity.
Methods: The antimicrobial activity of the extract at five different concentrations was tested against few common
human pathogenic microorganisms by agar disc diffusion assay. The Minimum Inhibitory Concentration of the
extract was determined by the modified resazurin method. Streptomycin (10 μg/ml) and amphotericin B (10 μg/ml)
were used as standards for antibacterial and antifungal study respectively. Few phenolic compounds were
identified and quantified by standard HPTLC technique.
Results: The zone of inhibition was extremely great for P. aeruginosa (25 mm), S. aureus (20 mm) and C. albicans
(19 mm). MIC value was the least at 0.03 mg/ml for bacteria: K. pneumoniae, S. dysenteriae and E. coli and 0.31 mg/ml
for fungi: C. albicans and T. mentagrophytes. Moreover, through HPTLC analysis few phenolic compounds were
quantified, among which catechin content was found to be the highest (3.06%), followed by gallic acid (0.27%) and
quercetin (0.04%).
Conclusions: The results therefore clearly indicates that the crude extract from N. nouchali seeds could be used as a
potential source of natural antimicrobial agent owing to the presence of the phytoconstituent catechin in abundance
along with other active compounds and supports the traditional use of the plant in the treatment of infections.
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Infectious diseases are disorders caused by bacteria, fungi,
virus or parasites [1]. According to the WHO, infectious
diseases are a significant cause of morbidity and mortality
worldwide, accounting for 50% of all deaths in tropical
countries. During the last decade, several reports indicated
that bacterial strains are resistant against almost all clinic-
ally available antibiotics [2,3]. Certainly the wide use and
misuse of antibiotics have led to a situation of spreading re-
sistant bacteria. The first line antimicrobials were both ef-
fective and affordable; however with the onset of resistance,* Correspondence: gricildashoba@gmail.com
P.G. & Research Department of Zoology, Voorhees College, Vellore,
Tamilnadu 632001, India
© 2014 Parimala and Shoba; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.newer treatments are proving too costly. They are not with-
out side effects. Therefore the search for new antimicrobial
agents is becoming a hot topic since fatal opportunistic in-
fections are registered every year.
Although many have been treated by conventional
pharmaceutical approaches, there is a growing interest in
the use of natural products by general public [4]. Medi-
cinal plants are found to be a better choice with wide
range of bioactive compounds [5]. They are perceived to
be non-toxic, safe, effective and sometimes the only source
of health care available to the poor [6]. That is why nearly
80% of the people are dependent, wholly or partially on
plant-based drugs [7]. Indeed, medicinal plants with anti-
microbial properties are being increasingly reported fromCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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from higher plants open up a new source of antimicrobial
agents with possible novel mechanisms of action [8]. The
phytoconstituents of such plants are responsible for their
pharmacological activity. Secondary metabolites of plant
origin appear to be one of the alternatives for the control
of antibiotic-resistant human pathogens. They become the
base for the development of new drugs. The wide arrays of
active compounds affect the behaviour of microorganisms
in such a way that they are toxic to the pathogens [9].
However due to their antibacterial, antifungal and antiviral
activity, phenolic compounds of plant origin have gained
interest in the recent years [10].
Nymphaea nouchali (synonym: Nymphaea stellata), is
a perennial aquatic herb belonging to the family Nym-
phaeaceae. It is commonly known as the white water lily.
It is an important and well-known medicinal plant,
widely used in Ayurveda and Siddha system of medi-
cines for the treatment of diabetes, inflammation, liver
disorders, urinary disorders and as a bitter tonic. The
fruit of this plant is globose containing round, flask-
shaped seeds. The seeds are used as stomachic and re-
storative. The seeds are also prescribed as diet for
diabetes in the ayurvedic system of medicine [11]. Earlier
studies have reported the seeds to possess significant
antioxidant [12], antidiabetic [13] and antihepatotoxic
activity [14]. Glycosides, phenols, tannins, flavonoids, sa-
ponins and alkaloids are also reported in the seeds [12].
Recently, nymphasterol, a new steroid has been isolated
and identified from the seeds [15].
Our study was focused on the evaluation of hydroalco-
holic extract of N. nouchali seeds against few pathogenic
microbes. Standardization of thin layer chromatograms
for the identification and quantification of certain phen-
olic compounds has been done. This is the first report




Culture media for microbial studies were obtained from
Himedia Laboratories Pvt. Ltd., Mumbai, India. Pure com-
pounds quercetin, gallic acid and catechin for HPTLC
studies were procured from Sigma Chemicals, Bangalore,
India. Silica gel GF254 TLC plates were purchased from
Merck (Darmstadt, Germany). Other solvents and chemi-
cals used were of analytical grade.
Plant material
Seed samples were collected from the plant N. nouchali
at a pond in Kanyakumari District, India. The plant was
identified by Prof. Dr. Jayaraman, Plant Anatomy Re-
search Centre (PARC), Chennai and a voucher specimen
was deposited at the herbarium of PARC for futurereference [PARC/2012/1248]. The samples were collected
into plastic zip-lock bags with appropriate labeling and
stored until it was taken to the laboratory. The seeds were
then washed with distilled water and open air-dried away
from sunlight.
Preparation of plant extract
Extraction was performed by hot percolation method
using soxhlet apparatus. About 250 g of the coarsely
powdered N. nouchali seeds was extracted in 500 ml of
70% ethanol by continuous hot extraction method at 50°C.
The extract with the solvent was decanted from the soxh-
let apparatus and the filtrate was evaporated for the total
elimination of solvent using a Rota flash vacuum evapor-
ator at 50°C. The concentrated liquid extract obtained was
then transferred to a china dish and kept in a water bath
to dry. The residual extract (NHS) was transferred and
stored in an air tight container.
Microorganisms
A total of ten bacterial cultures (Bacillus cereus, Brucella,
Enterococcus faecalis, Escherichia coli, Klebsiella pneumo-
niae, Pseudomonas aeruginosa, Salmonella typhi, Shigella
dysenteriae, Staphylococcus aureus, Vibrio cholerae) and
five fungal cultures (Aspergillus niger, Candida albicans,
Curvularia, Penicillium, Trichophyton mentagrophytes)
were used in this study. All the cultures were obtained
from Royal Bioresearch Centre, Velachery, Chennai. The
cultures were stored on nutrient agar slants at 4°C and
were sub-cultured on nutrient agar medium before anti-
microbial testing.
Inoculum preparation
The starter cultures, in tubes with 2 ml of nutrient broth
were inoculated with the microorganisms for bioassay
and incubated for 24 h time period at 37°C.
Determination of antimicrobial activity
Antimicrobial activity was tested using disc diffusion
assay [16]. Mueller Hinton Agar and Potato Dextrose
Broth were used for bacterial and fungal susceptibility
test respectively. The nutrient mediums were transferred
into one-fourth volume of the plate. After solidification,
the inoculums were spread on the solid plates with ster-
ile swab moistened with the microbial suspension. Dif-
ferent concentrations (1000, 500, 250, 125, 62.5 μg/ml)
of NHS extract in 1% v/v DMSO were prepared as indi-
vidual stocks in sterile vials. Whatman filter No.1 paper
discs were soaked with the extracts and air-dried thor-
oughly before the assay. The plates were incubated for
24 h at 37°C. The inhibition of bacterial and fungal
growth was determined by measuring the diameter of
the clear zone around each disc. The sterile discs soaked
with 1% DMSO served as negative control. Standard
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10 μg/ml were used as standards for antibacterial and
antifungal test respectively. Average of triplet readings
for each microorganism was recorded.
Determination of minimum inhibitory concentration
The minimum inhibitory concentration (MIC) was de-
termined by the modified resazurin method [17]. Test
was carried out in a 96 well plate under aseptic condi-
tions. A volume of 100 μl of test material (a stock con-
centration of 10 μg/ml for standards and 10 mg/ml for
NHS extract in 1% DMSO) was pipetted into the first
row of the plate. To all other wells 50 μl of nutrient
broth was added and serial dilutions were performed. To
this resazurin indicator solution was added. 30 μl of
3.3X strength isosensitised broth was added to each well
to ensure that the final volume was single strength of
the nutrient broth. Finally, 10 μl of bacterial suspension
was added to each well to achieve a concentration of
5 × 105 cfu/ml (for bacterial isolates) and/or 10 μl of fun-
gal suspension was added to each well to achieve a con-
centration of 105 spores/ml (for fungal isolates). Each
plate had a set of controls. The plates were prepared in
triplicate, and placed in an incubator set at 37°C for
24 h. The colour change was then assessed visually. Any
colour change from purple to pink was recorded as posi-
tive. The lowest concentration at which colour change
occurred was taken as the MIC value.
Thin layer chromatography study
Based on the preliminary qualitative phytochemical
screening, TLC studies were performed with known
standards. A Camag TLC system equipped with Camag
Linomat V, an automated TLC sample spotter, Camag
glass with trough chamber (20 × 10 cm) was used for the
analysis. The NHS extract was separated in suitable mo-
bile phase along with standards.
Identification and quantification of quercetin
A stock solution of quercetin (100 μg/ml) was prepared
in methanol. Working solutions were prepared by ap-
propriate dilution of the stock solution with the same
solvent. Quantification was performed by external stand-
ard method using pure quercetin as standard. Sample
solution was applied on the TLC plate and developed
with mobile phase chloroform: ethyl acetate: formic acid:
methanol (2.5:2:0.4:0.2, v/v/v/v). Densitometric scanning
was performed at 412 nm. Peak areas were recorded and
the amount of quercetin was calculated using the cali-
bration curve.
Identification and quantification of gallic acid
A stock solution of gallic acid (100 μg/ml) was prepared in
methanol. Working solutions were prepared by appropriatedilution of the stock solution with the same solvent. Quan-
tification was performed by external standard method using
pure gallic acid as standard. Sample solution was applied
on the TLC plate and developed with mobile phase
chloroform: ethyl acetate: formic acid (2.5:2:0.8, v/v/v).
Densitometric scanning was performed at 280 nm. Peak
areas were recorded and the amount of gallic acid was cal-
culated using the calibration curve.
Identification and quantification of catechin
A stock solution of catechin (1 mg/ml) was prepared in
methanol. Working solutions were prepared by appro-
priate dilution of the stock solution with the same solv-
ent. Quantification was performed by external standard
method using pure catechin as standard. Sample solu-
tion was applied on the TLC plate and developed with
mobile phase chloroform: ethyl acetate: formic acid:
methanol (2.5:2:0.8:0.2, v/v/v). Densitometric scanning
was performed at 280 nm. Peak areas were recorded and




The antibacterial activity of NHS extract varied depend-
ing on the various concentrations used and the tested
microorganisms (Figure 1). The zones of inhibition
ranged between 8 mm and 25 mm diameter. Almost all
the microorganisms were susceptible to NHS extract,
though in different concentrations. The present study
revealed that the crude extract possessed significant in-
hibitory activity against P. aeruginosa, S. aureus and
V. cholerae even at low concentration of 62.5 μg/ml. The
growth of E. faecalis was inhibited at 125 μg/ml of ex-
tract. The extract also effectively inhibited E. coli and
S. dysentriae at 250 μg/ml concentration. The rest of
the tested microorganisms started forming zones of in-
hibition at high concentrations of 500 μg/ml. However
at 1000 μg/ml, the highest antibacterial activity was
recorded against P. aeruginosa (25 mm), followed by
S. aureus (20 mm), E. coli (15 mm), B. cereus (14 mm)
and S. dysenteriae (14 mm) and the least activity was re-
corded against E. faecalis (11 mm). Surprisingly, the
NHS extract at 500 μg/ml concentration, effectively sup-
pressed P. aeruginosa (20 mm) which was greater than
the standard antibiotic streptomycin (17 mm) used as
reference (Table 1).
Antifungal activity
The NHS extract also showed significant fungal growth in-
hibition against all the tested fungi comparable to the
standard amphotericin B (Table 2). Among the five tested
fungi, the best antifungal activity was obtained with
the extract against C. albicans showing 19 mm diameter
Figure 1 Antimicrobial activity of Nymphaea nouchali seed extract using disc diffusion assay. Culture plates showing zones of inhibition.
T1: 1000 μg/ml NHS, T2: 500 μg/ml NHS, T3: 250 μg/ml NHS, T4: 125 μg/ml NHS, T5: 62.5 μg/ml NHS, NC: Negative control 1% DMSO,
S: Streptomycin, A: Amphotericin B.
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of the drug, notable inhibition similar to the standard
used was observed. Interestingly, T. mentagrophytes and
Penicillium were susceptible to NHS extract at 250 μg/ml,
while amphotericin B did not exhibit fungicidal property
against these two species at all (Figure 1).
Minimum inhibitory concentration (MIC)
Among the ten tested bacterial strains, the extract had the
lowest MIC (0.03 mg/ml) for K. pneumoniae, S. dysenteriae
and E. coli and the extract had the highest MIC (0.62 mg/ml)Table 1 Antibacterial activity of Nymphaea nouchali seed extr
Microorganisms Zon
1000 μg/ml 500 μg/ml 250 μg/ml 125
Gram negative bacteria
S. typhi 12 9 -
P. aeruginosa 25 20 17
E. coli 15 14 11
V. cholerae 13 10 9
Brucella 13 8 -
K. pneumoniae 13 11 -
S. dysenteriae 14 9 8
Gram positive bacteria
S. aureus 20 18 15
B. cereus 14 9 -
E. faecalis 11 9 8for S. aureus (Table 3). The MIC values for the
remaining microorganisms ranged between 0.07 mg/ml
and 0.31 mg/ml (Figure 2). On the other hand, with
respect to fungi (Figure 3), the MIC was the least for
C. albicans and T. mentagrophytes (0.31 mg/ml) (Table 4).
HPTLC analysis
HPTLC analysis was performed for three phenolic phy-
tocompounds namely: quercetin, gallic acid and cat-
echin. The amount of quercetin in NHS extract was
estimated to be 0.04%. Similarly, the obtained value ofact in different concentrations
e of inhibition (mm)
μg/ml 62.5 μg/ml DMSO 1% v/v Streptomycin 10 μg/ml
- - - 19
15 11 - 17
- - - 16
9 8 - 20
- - - 20
- - - 19
- - - 20
12 11 - 23
- - - 23
8 - - 19
Table 2 Antifungal activity of Nymphaea nouchali seed extract in different concentrations
Microorganisms Zone of inhibition (mm)
1000 μg/ml 500 μg/ml 250 μg/ml 125 μg/ml 62.5 μg/ml DMSO (1% v/v) Amphotericin B (10 μg/ml)
C. albicans 19 18 15 13 11 - 11
T. mentagrophytes 9 8 7 - - - -
A. niger 10 9 - - - - 10
Penicillium 10 9 8 - - - -
Curvularia 11 10 - - - - 10
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tent in the extract was also evaluated and found to be
3.06% of NHS drug (Figure 4).
Discussion
Antimicrobial activity can be regarded as a very import-
ant study, particularly at this specific period of human
history due to bacterial resistance that is constantly im-
posing new scientific challenges. In spite of great devel-
opment in drug therapy, infectious diseases remain as
the most common reasons for mortality in many devel-
oping countries. Resistance to antimicrobial agents has
become an increasingly important and pressing global
problem. To counter the emergence of resistant micro-
organisms, considerable resources have been invested in
the search for new antimicrobials.
It is well known that plants synthesize a diverse array
of secondary metabolites, which are involved in defense
mechanisms, and in the last few years it is recognized
that some of these molecules have health beneficial ef-
fects including antimicrobial properties [18]. According
to the WHO, plants are a source of compounds that
have the ability to combat disease. Nymphaea nouchali
is a well-known medicinal plant in the Indian traditional
system of medicine. Due to their various biological activ-
ities, the plant and its compounds are continuously
under investigation.Table 3 Minimum Inhibitory Concentration of Nymphaea











E. coli 0.03Hence the present study was focused in evaluating the
antimicrobial property of the hydroalcoholic seed extract
of N. nouchali. The NHS extract showed notable anti-
bacterial activity against S. typhi, P. aeruginosa, E .coli
and V. cholerae. It also showed remarkable activity
against S. aureus and B. cereus. Thus it is clear that the
NHS extract is effective in controlling both gram-
negative and gram-positive bacteria. This evidence opens
possibilities to the fact that the extract contains com-
pounds that may act by synergism or additive effect
which in turn is responsible for its pharmacological ac-
tivity [19].
Among the phytocompounds, polyphenols or phenolic
compounds are a group of secondary metabolites that
are adequately found in medicinal plants with more than
8000 identified compounds [20], and have been tested in
clinical and experimental studies as antimicrobials [21].
Quality control which is an important challenge in
present scenario can be addressed with reliable and sen-
sitive quantization of important biological active metab-
olite in the sample [22]. High Performance Thin Layer
Chromatography is one of the modern sophisticated
techniques than can be used for evaluating the potency,
authenticity, quality and purity of crude drugs [23].
HPTLC offers better resolution, and estimation of active
constituents can be done with reasonable accuracy in a
shorter time [24]. Polyphenols found in medicinal
plants have been extensively investigated against a wide
range of microorganisms, and among them tannins and
flavanols received more attention due to its broad
spectrum and the fact that most of them are able to
suppress microbial virulence factors [25]. So the present
study also demonstrates the quantization of few phen-
olic compounds like quercetin (Q), gallic acid (GA) and
catechin (CA).
Flavonoids like quercetin and catechin are becoming
the subject of medical research [26]. Flavonoids interfere
with specific intracellular or surface enzymes and many
bacterial virulence factors such as toxins, enzymes and
signal receptors [27]. Xanthomonas phaseoli showed a
similar antimicrobial activity confirming that flavonoids
may have been responsible for its activity [28]. CA con-
tent in NHS extract was the highest among the tested
Figure 2 Plates showing MIC of Nymphaea nouchali seed extract against the tested bacteria. A: B. cereus, B: K. pneumoniae, C: S. aureus,
D: E. faecalis, E: S. dysenteriae, F: V. cholerae, G: P. aeruginosa, H: Brucella, I: S. typhi, J: E. coli, 1 – 9: 10, 5, 2.5, 1.25, 0.62, 0.31, 0.15, 0.07, 0.03 mg/ml
NHS, 10: streptomycin, 11: Control containing DMSO, 12: Culture alone.
Figure 3 Plate showing MIC of Nymphaea nouchali seed extract
against the tested fungi. A: Curvularia, B: A. niger, C: Penicillium,
D: T. mentagrophytes, E: C. albicans, 1: NHS without culture, 2–7: 10,
5, 2.5, 1.25, 0.62, 0.31 mg/ml NHS, Amp: Amphotericin B, C: Control
containing DMSO.
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been extensively researched due to their occurrence in
green teas. CAs from Camellia sinensis showed pro-
found antibacterial activity against Shigella, Vibrio and
S. mutans [29]. The CAs in NHS extract might have
inactivated cholera toxin in V. cholerae due to complex-
ing mechanism similar to that which has been reported
earlier [30]. CAs appear to have greater activity against
gram-positive than gram-negative bacteria due to the
presence of lipopolysaccharide acting as a barrier [31].
However, recently it has been established that in gram-
negative bacteria, cell surface structures lacking O antigen
and core polysaccharide have increased the sensitivity of
CAs [32]. Black tea polyphenols are also known to haveTable 4 Minimum Inhibitory Concentration of Nymphaea







Figure 4 HPTLC fingerprint profile. A: Standard quercetin, B: Standard gallic acid, C: Standard catechin, D: Quercetin in NHS extract, E: Gallic
acid in NHS extract, F: Catechin in NHS extract.
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methicillin-resistant S. aureus [33].
Increased level of CA and epicatechin in the regenerated
bark and leaves of Saraca asoca showed importance of
these metabolites in prevention of infection [22]. 3-o-
octanoyl CA have shown to cause a reduction of 1000-fold
or more in viable counts of MRSA-YK, S. aureus NCTC
6571 and EMRSA-16 due to the formation of pseudomul-
ticellular aggregates both in antibiotic sensitive and anti-
biotic resistance strains of S. aureus [34]. Sub-inhibitory
concentrations of tea CAs have also suppressed the oppor-
tunistic pathogen S. aureus to β-lactam antibiotics and
relatively low concentration of epicatechin have sensitized
MRSA clinical isolates to levels of oxacillin by affecting
both virulence and antibiotic resistance by perturbing the
function of key processes associated with the bacterial
cytoplasmic membranes [35].
Antimicrobial effects of CAs were also observed
against Staphylococcus strains, which cause suppuration-
related inflammation and bedsores, and against Candida,
which causes oral candidiasis, suggesting that NHS extract
may aid in the prevention of oral candidiasis and sup-
puration [36]. There are several reports about the po-
tential antifungal activity of polyphenols for treating oral
candidiasis. Gel-entrapped catechins (GEC) inhibited the
growth of Candida strains suggesting that hydrogen
peroxide may be involved in the antimicrobial activityof CA [37]. Black tea extract containing CA completely
inhibited the growth of T. mentagrophytes [38]. Surpris-
ingly, the C. albicans was unaffected with heat treatment
of tea CAs [39].
GA is reported to be highly antimicrobial against
gram-negative pathogens. Salmonella tested against GA
showed to have varying degrees of antimicrobial activity.
Studies have reported B. cereus isolates sensitive to GA
[40]. On examination of the activity of three extracts
from the fruiting bodies of the tree Terminalia chebula
RETS against methicillin-sensitive and MRSA, GA deriv-
atives were more effective against both types of S. aureus
[41]. E. coli was observed to have a very similar anti-
microbial activity against GA with MIC of 15 ppm after
60 h of incubation [42]. GA had antimicrobial activity
against the bacteria tested, with MIC of 500 μg/ml for
P. aeruginosa; 1500 μg/ml for E. coli and 1750 μg/ml for
S. aureus. GA is believed to cause irreversible changes in
membrane properties through hydrophobicity changes,
decrease of negative surface charge and occurrence of
local rupture or pore formation in the cell membranes
with consequent leakage of essential intracellular constit-
uents [18]. Therefore, GA in NHS could have partly
contributed to its action against gram-negative microor-
ganisms in the study.
Hence, the antimicrobial activity may be due to the
presence of catechin and gallic acid in the extract which
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property. It is therefore conceivable that this extract
could be used against infections caused by the microbes
against which it has shown pronounced effects. The re-
sults showed a good correlation between the reported
uses of N. nouchali in traditional medicine against infec-
tious diseases. This study may not be adequate to suggest
potential antibiotic agent considering the MIC values and
the zones of inhibition. However, this approach could be
considered as preliminary step to find out promising lead
molecules and the possible mechanism of action by which
it inhibits microorganisms.
Conclusions
The demonstration of activity against both gram-negative
and gram-positive bacteria, and fungi is an indication that
Nymphaea nouchali seeds can be a source of bioactive
substances. The study also reports HPTLC analysis of
quercetin, gallic acid and catechin from N. nouchali seed
extract. The extract containing catechin and gallic acid
must have contributed to its antimicrobial activity. The
overall study, thus, emphasizes the potency of N. nouchali
as a green and sustainable source of new broad spectrum
of antimicrobial products. Because of its interesting bio-
logical activity, specialists can focus their increasing inter-
est towards this plant. However, further research is
required to determine the compound that has contributed
to the antimicrobial activity of the extract and its exact
mode of action.
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